Search research articles
Contact Us
Filters
Showing results (311-320 of 564) with videos related to
Page
of 57
Sort By:
Prostate Cancer and Prostatic Diseases
|
May 15, 2020
Concurrent or layered treatment with radium-223 and enzalutamide or abiraterone/prednisone: real-world clinical outcomes in patients with metastatic castration-resistant prostate cancer
Neal Shore, Celestia S Higano, Daniel J George, et al.
The New England Journal of Medicine
|
June 28, 2018
Enzalutamide in Men with Nonmetastatic, Castration-Resistant Prostate Cancer
Maha Hussain, Karim Fizazi, Fred Saad, et al.
The Oncologist
|
June 17, 2024
TRIUMPH: phase II trial of rucaparib monotherapy in patients with metastatic hormone-sensitive prostate cancer harboring germline homologous recombination repair gene mutations
Mark C Markowski, Cora N Sternberg, Hao Wang, et al.
European Urology
|
April 21, 2018
Update on Systemic Prostate Cancer Therapies: Management of Metastatic Castration-resistant Prostate Cancer in the Era of Precision Oncology
Philipp Nuhn, Johann S De Bono, Karim Fizazi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 20, 2009
Docetaxel plus oblimersen sodium (Bcl-2 antisense oligonucleotide): an EORTC multicenter, randomized phase II study in patients with castration-resistant prostate cancer
C N Sternberg, H Dumez, H Van Poppel, et al.
ESMO Open
|
November 17, 2023
Avelumab first-line maintenance treatment for advanced urothelial carcinoma: review of evidence to guide clinical practice
P Grivas, E Grande, I D Davis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 27, 2026
Radiographic Progression With and Without Prostate-Specific Antigen Rise in Patients With Advanced Prostate Cancer Treated With Enzalutamide
Andrew J Armstrong, Arun A Azad, Taro Iguchi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 17, 2009
Pemetrexed in combination with oxaliplatin as a first-line therapy for advanced gastric cancer: a multi-institutional phase II study
L Celio, C N Sternberg, R Labianca, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1986
Phase I/II trial of intravesical methotrexate for superficial bladder tumors
C N Sternberg, A Yagoda, N H Bander, et al.
The Journal of Urology
|
March 1, 1988
Neoadjuvant M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) effect on the primary bladder lesion
H I Scher, A Yagoda, H W Herr, et al.
Page
of 57
Search research articles
Search
Showing results (311-320 of 564) with videos related to
Sort By:
Page
of 57
Prostate Cancer and Prostatic Diseases
|
May 15, 2020
Concurrent or layered treatment with radium-223 and enzalutamide or abiraterone/prednisone: real-world clinical outcomes in patients with metastatic castration-resistant prostate cancer
Neal Shore, Celestia S Higano, Daniel J George, et al.
The New England Journal of Medicine
|
June 28, 2018
Enzalutamide in Men with Nonmetastatic, Castration-Resistant Prostate Cancer
Maha Hussain, Karim Fizazi, Fred Saad, et al.
The Oncologist
|
June 17, 2024
TRIUMPH: phase II trial of rucaparib monotherapy in patients with metastatic hormone-sensitive prostate cancer harboring germline homologous recombination repair gene mutations
Mark C Markowski, Cora N Sternberg, Hao Wang, et al.
European Urology
|
April 21, 2018
Update on Systemic Prostate Cancer Therapies: Management of Metastatic Castration-resistant Prostate Cancer in the Era of Precision Oncology
Philipp Nuhn, Johann S De Bono, Karim Fizazi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 20, 2009
Docetaxel plus oblimersen sodium (Bcl-2 antisense oligonucleotide): an EORTC multicenter, randomized phase II study in patients with castration-resistant prostate cancer
C N Sternberg, H Dumez, H Van Poppel, et al.
ESMO Open
|
November 17, 2023
Avelumab first-line maintenance treatment for advanced urothelial carcinoma: review of evidence to guide clinical practice
P Grivas, E Grande, I D Davis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 27, 2026
Radiographic Progression With and Without Prostate-Specific Antigen Rise in Patients With Advanced Prostate Cancer Treated With Enzalutamide
Andrew J Armstrong, Arun A Azad, Taro Iguchi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 17, 2009
Pemetrexed in combination with oxaliplatin as a first-line therapy for advanced gastric cancer: a multi-institutional phase II study
L Celio, C N Sternberg, R Labianca, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1986
Phase I/II trial of intravesical methotrexate for superficial bladder tumors
C N Sternberg, A Yagoda, N H Bander, et al.
The Journal of Urology
|
March 1, 1988
Neoadjuvant M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) effect on the primary bladder lesion
H I Scher, A Yagoda, H W Herr, et al.
Page
of 57